Amplia Therapeutics Limited (ATX)
Market Closed
ASX ASX Primary 35.47M Market Cap
- P/E Ratio
0% Div Yield
472,432 Volume
0 Eps
Want to track ATX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ATX Amplia Therapeutics Limited 25 Nov 2025 | | - | - |
| ATX Amplia Therapeutics Limited 28 May 2025 | | - | - |
| ATX Amplia Therapeutics Limited 18 Nov 2024 | | - | - |
| ATX Amplia Therapeutics Limited 23 Aug 2024 | | - | - |
| ATX Amplia Therapeutics Limited 30 May 2024 | | - | - |
| ATX Amplia Therapeutics Limited 29 Apr 2024 | | - | - |
| ATX Amplia Therapeutics Limited 30 Jan 2024 | | - | - |
| ATX Amplia Therapeutics Limited 15 Nov 2023 | | - | - |
| ATX Amplia Therapeutics Limited 29 Nov 2016 | | - | - |
| ATX Amplia Therapeutics Limited 22 Jun 2016 | | - | - |
ATX Earnings Reports FAQ
What is the earnings per share (EPS) for ATX?
The current EPS is 0.
What is the company's earnings growth rate?
Amplia Therapeutics Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Amplia Therapeutics Limited has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Amplia Therapeutics Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ATX at this time, as Amplia Therapeutics Limited has no recent EPS data to calculate it.
